242 related articles for article (PubMed ID: 32106239)
81. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
82. Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
De Paepe KN; De Keyzer F; Wolter P; Bechter O; Dierickx D; Janssens A; Verhoef G; Oyen R; Vandecaveye V
J Magn Reson Imaging; 2018 Oct; 48(4):897-906. PubMed ID: 29656584
[TBL] [Abstract][Full Text] [Related]
83. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
[TBL] [Abstract][Full Text] [Related]
84. Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI.
Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
Diagn Interv Imaging; 2019 May; 100(5):295-302. PubMed ID: 30704946
[TBL] [Abstract][Full Text] [Related]
85. [Use of whole-body diffusion-weighted magnetic resonance imaging for the diagnosis of and therapeutic response in multiple myeloma].
Puskás T; Henits I
Orv Hetil; 2014 Aug; 155(31):1241-5. PubMed ID: 25095285
[TBL] [Abstract][Full Text] [Related]
86. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
[TBL] [Abstract][Full Text] [Related]
87. [Treatment options and prognosis in newly diagnosed multiple myeloma patients].
Wang L; Tang W; Wang Y; Xu L; Zhao WL; Wu W; Chen YB; Shen ZX; Hu J
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):308-12. PubMed ID: 21729598
[TBL] [Abstract][Full Text] [Related]
88. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
Gu J; Chan T; Zhang J; Leung AY; Kwong YL; Khong PL
AJR Am J Roentgenol; 2011 Sep; 197(3):W384-91. PubMed ID: 21862763
[TBL] [Abstract][Full Text] [Related]
89. Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity.
Tsujikawa T; Oikawa H; Tasaki T; Hosono N; Tsuyoshi H; Yoshida Y; Yamauchi T; Kimura H; Okazawa H
Eur J Radiol; 2019 Sep; 118():223-230. PubMed ID: 31439246
[TBL] [Abstract][Full Text] [Related]
90. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
Mosavi F; Laurell A; Ahlström H
Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
[TBL] [Abstract][Full Text] [Related]
91. Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma.
Ahmed N; Sriskandarajah P; Burd C; Riddell A; Boyd K; Kaiser M; Messiou C
Br J Radiol; 2019 May; 92(1097):20180822. PubMed ID: 30676781
[TBL] [Abstract][Full Text] [Related]
92. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
Li S; Sun F; Jin ZY; Xue HD; Li ML
J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
[TBL] [Abstract][Full Text] [Related]
93. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.
Shortt CP; Gleeson TG; Breen KA; McHugh J; O'Connell MJ; O'Gorman PJ; Eustace SJ
AJR Am J Roentgenol; 2009 Apr; 192(4):980-6. PubMed ID: 19304704
[TBL] [Abstract][Full Text] [Related]
94. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus
Sun W; Li M; Gu Y; Sun Z; Qiu Z; Zhou Y
AJR Am J Roentgenol; 2020 Feb; 214(2):446-454. PubMed ID: 31799866
[No Abstract] [Full Text] [Related]
95. Development of a Semiquantitative Whole-Body MRI Scoring System for Multiple Myeloma.
Kim DK; Jung JY; Kim H; Lee S; Lee SY; Lee S; Park SS; Min CK
Radiology; 2023 Sep; 308(3):e230667. PubMed ID: 37668524
[TBL] [Abstract][Full Text] [Related]
96. Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging.
Lin C; Luciani A; Belhadj K; Deux JF; Kuhnowski F; Maatouk M; Beaussart P; Cuenod CA; Haioun C; Rahmouni A
Radiology; 2010 Feb; 254(2):521-31. PubMed ID: 20093523
[TBL] [Abstract][Full Text] [Related]
97. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
98. Spinal multiparametric MRI and DEXA changes over time in men with prostate cancer treated with androgen deprivation therapy: a potential imaging biomarker of treatment toxicity.
Martin J; Arm J; Smart J; Palazzi K; Capp A; Ainsworth P; Cowin G
Eur Radiol; 2017 Mar; 27(3):995-1003. PubMed ID: 27287481
[TBL] [Abstract][Full Text] [Related]
99. Inter-observer agreement of baseline whole body MRI in multiple myeloma.
Croft J; Riddell A; Koh DM; Downey K; Blackledge M; Usher M; Boyd K; Kaiser M; Messiou C
Cancer Imaging; 2020 Jul; 20(1):48. PubMed ID: 32665028
[TBL] [Abstract][Full Text] [Related]
100. [Efficacy and Influencing Factors of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Retrospective Analysis].
Zhang BL; Zhou J; Zhang GL; Gui RR; Lin QD; Zu YL; Yu FC; Zhao HF; Li Z; Wang J; Fu YW; Zhang LN; Zhou H; Fang BJ; Song YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1414-1419. PubMed ID: 30295260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
